ArticleIn vivo (Athens, Greece)

Glycemic Control in Patients Undergoing Treatment With Paritaprevir/Ombitasvir/Ritonavir and Dasabuvir for Chronic Hepatitis C Infection.

Xenia Bacinschi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.